<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9214969</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2488</journal-id>
<journal-id journal-id-type="nlm-ta">Methods Mol Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Methods Mol. Biol.</journal-id>
<journal-title-group>
<journal-title>Methods in molecular biology (Clifton, N.J.)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1064-3745</issn>
<issn pub-type="epub">1940-6029</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28986865</article-id>
<article-id pub-id-type="pmc">7325486</article-id>
<article-id pub-id-type="doi">10.1007/978-1-4939-7321-7_1</article-id>
<article-id pub-id-type="manuscript">NIHMS1600275</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>NMDA receptors in the central nervous system</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hansen</surname>
<given-names>Kasper B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yi</surname>
<given-names>Feng</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Perszyk</surname>
<given-names>Riley</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Menniti</surname>
<given-names>Frank S.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Traynelis</surname>
<given-names>Stephen F.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT.</aff>
<aff id="A2"><label>2</label>Center for Biomolecular Structure and Dynamics, University of Montana, Missoula, MT.</aff>
<aff id="A3"><label>3</label>Department of Pharmacology, Emory University School of Medicine, Atlanta, GA.</aff>
<aff id="A4"><label>4</label>MindImmune Therapeutics, Inc., and George &amp; Anne Ryan Institute for Neuroscience, Kingston, RI, USA.</aff>
<author-notes>
<corresp id="CR1"><bold>Corresponding author:</bold> Kasper B. Hansen (<email>kasper.hansen@mso.umt.edu</email>)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>6</month>
<year>2020</year>
</pub-date>
<volume>1677</volume>
<fpage>1</fpage>
<lpage>80</lpage>
<!--elocation-id from pubmed: 10.1007/978-1-4939-7321-7_1-->
<abstract id="ABS1">
<p id="P1">NMDA-type glutamate receptors are ligand-gated ion channels that mediate a major component of excitatory neurotransmission in the central nervous system (CNS). They are widely distributed at all stages of development and are critically involved in normal brain functions, including neuronal development and synaptic plasticity. NMDA receptors are also implicated in the pathophysiology of numerous neurological and psychiatric disorders, such as ischemic stroke, traumatic brain injury, Alzheimerâ€™s disease, epilepsy, mood disorders, and schizophrenia. For these reasons, NMDA receptors have been intensively studied in the past several decades to elucidate their physiological roles and to advance them as therapeutic targets. Seven NMDA receptor subunits exist that assemble into a diverse array of tetrameric receptor complexes, which are differently regulated, have distinct regional and developmental expression, and possess a wide range of functional and pharmacological properties. The diversity in subunit composition creates NMDA receptor subtypes with distinct physiological roles across neuronal cell types and brain regions, and enables precise tuning of synaptic transmission. Here, we will review the relationship between NMDA receptor structure and function, the diversity and significance of NMDA receptor subtypes in the CNS, as well as principles and rules by which NMDA receptors operate in the CNS under normal and pathological conditions.</p>
</abstract>
<kwd-group>
<kwd>Ionotropic glutamate receptor</kwd>
<kwd>neurotransmitter</kwd>
<kwd>NMDA</kwd>
<kwd>ion channel</kwd>
<kwd>regulation</kwd>
<kwd>structure-function</kwd>
<kwd>disease</kwd>
<kwd>synaptic transmission</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>